首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1067485

肝臟癌症治療藥的全球市場:2022～2026年

Global Liver Cancer Drugs Market 2022-2026

出版日期: 2022年03月23日 | 出版商:

TechNavio | 英文 120 Pages | 訂單完成後即時交付

價格

簡介目錄

全球肝臟癌症治療藥的市場規模在2022年～2026年間，預測將成長到52億9,000萬美元，在預測期間內年複合成長率預計將為14.67％。

市場成長的主要因素有肝臟癌症罹患率的增加，診斷方法的進步，有利的償付方案。

本報告提供全球肝臟癌症治療藥市場相關調查分析，提供市場規模，波特的五力分析，各類型市場區隔，客戶形勢，地區形勢，供應商分析等相關資訊。

地區市場區隔
地區比較
北美:市場規模與預測(2021～2026年)
歐洲:市場規模與預測(2021～2026年)
亞洲:市場規模與預測(2021～2026年)
其他地區(ROW):市場規模與預測(2021～2026年)
美國:市場規模與預測(2021～2026年)
德國:市場規模與預測(2021～2026年)
中國:市場規模與預測(2021～2026年)
加拿大:市場規模與預測(2021～2026年)
英國:市場規模與預測(2021～2026年)
市場機會:各地區形勢

第8章促進因素，課題，及趨勢

市場促進因素
市場課題
推動因素與課題的影響
市場趨勢

第9章業者情勢

概要
業者情勢
創新的形勢
產業的風險

第10章供應商分析

交易廠商
供應商的市場定位
AstraZeneca Plc
Bayer AG
Bristol-Myers Squibb Co.
Eisai Co. Ltd.
Eli Lilly and Co.
Eureka Therapeutics
Gilead Sciences Inc.
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Lion TCR Pte. Ltd
Merck and Co. Inc.

第11章附錄

調查範圍
包含和排除清單
貨幣換算比率(美元)
調查手法
簡稱的清單

簡介目錄

Product Code: IRTNTR72448

Technavio has been monitoring the liver cancer drugs market and it is poised to grow by $ 5.29 bn during 2022-2026 progressing at a CAGR of 14.67% during the forecast period. Our report on the liver cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of liver cancer, advancements in diagnostic methods, and favorable reimbursement scenario.

The liver cancer drugs market analysis includes the type segment and geographic landscape.

Technavio's liver cancer drugs market is segmented as below:

By Type

Immunotherapy
Targeted therapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the use of mABs as one of the prime reasons driving the liver cancer drugs market growth during the next few years. Also, the introduction of precision cancer medicine in liver cancer and increase in collaborations for liver cancer drug development will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on liver cancer drugs market covers the following areas:

Liver cancer drugs market sizing
Liver cancer drugs market forecast
Liver cancer drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liver cancer drugs market vendors that include Alnylam Pharmaceuticals Inc., AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., Eureka Therapeutics, Exelixis Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Lion TCR Pte. Ltd, Merck and Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc., and Q BioMed Inc. Also, the liver cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Immunotherapy - Market size and forecast 2021-2026
Exhibit 28: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
5.4 Targeted therapy - Market size and forecast 2021-2026
Exhibit 32: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AstraZeneca Plc
Exhibit 85: AstraZeneca Plc - Overview
Exhibit 86: AstraZeneca Plc - Product / Service
Exhibit 87: AstraZeneca Plc - Key news
Exhibit 88: AstraZeneca Plc - Key offerings
10.4 Bayer AG
Exhibit 89: Bayer AG - Overview
Exhibit 90: Bayer AG - Business segments
Exhibit 91: Bayer AG - Key news
Exhibit 92: Bayer AG - Key offerings
Exhibit 93: Bayer AG - Segment focus
10.5 Bristol-Myers Squibb Co.
Exhibit 94: Bristol-Myers Squibb Co. - Overview
Exhibit 95: Bristol-Myers Squibb Co. - Product / Service
Exhibit 96: Bristol-Myers Squibb Co. - Key offerings
10.6 Eisai Co. Ltd.
Exhibit 97: Eisai Co. Ltd. - Overview
Exhibit 98: Eisai Co. Ltd. - Business segments
Exhibit 99: Eisai Co. Ltd. - Key offerings
Exhibit 100: Eisai Co. Ltd. - Segment focus
10.7 Eli Lilly and Co.
Exhibit 101: Eli Lilly and Co. - Overview
Exhibit 102: Eli Lilly and Co. - Business segments
Exhibit 103: Eli Lilly and Co. - Key offerings
Exhibit 104: Eli Lilly and Co. - Segment focus
10.8 Eureka Therapeutics
Exhibit 105: Eureka Therapeutics - Overview
Exhibit 106: Eureka Therapeutics - Product / Service
Exhibit 107: Eureka Therapeutics - Key offerings
10.9 Gilead Sciences Inc.
Exhibit 108: Gilead Sciences Inc. - Overview
Exhibit 109: Gilead Sciences Inc. - Business segments
Exhibit 110: Gilead Sciences Inc. - Key news
Exhibit 111: Gilead Sciences Inc. - Key offerings
Exhibit 112: Gilead Sciences Inc. - Segment focus
10.10 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Exhibit 113: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibit 114: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibit 115: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
10.11 Lion TCR Pte. Ltd
Exhibit 116: Lion TCR Pte. Ltd - Overview
Exhibit 117: Lion TCR Pte. Ltd - Product / Service
Exhibit 118: Lion TCR Pte. Ltd - Key offerings
10.12 Merck and Co. Inc.
Exhibit 119: Merck and Co. Inc. - Overview
Exhibit 120: Merck and Co. Inc. - Business segments
Exhibit 121: Merck and Co. Inc. - Key news
Exhibit 122: Merck and Co. Inc. - Key offerings
Exhibit 123: Merck and Co. Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 124: Inclusions checklist
Exhibit 125: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 126: Currency conversion rates for US$
11.4 Research methodology
Exhibit 127: Research methodology
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations
- The market is led by the UK, Germany, and France. The market will experience moderate growth during the forecast period. One of the major factors is the increase in the prevalence of liver cancer in the region. Liver cancer can be caused due to various infectious diseases such as chronic hepatitis B infection and hepatitis C virus infections. Liver cancer is the 18th most common cancer in the UK. In Europe, 28% of the cases of liver cancer are due to chronic hepatitis B infection, and 21% of the cases are due to hepatitis C virus infections.

Exhibits

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AstraZeneca Plc - Overview
Exhibits86: AstraZeneca Plc - Product / Service
Exhibits87: AstraZeneca Plc - Key news
Exhibits88: AstraZeneca Plc - Key offerings
Exhibits89: Bayer AG - Overview
Exhibits90: Bayer AG - Business segments
Exhibits91: Bayer AG - Key news
Exhibits92: Bayer AG - Key offerings
Exhibits93: Bayer AG - Segment focus
Exhibits94: Bristol-Myers Squibb Co. - Overview
Exhibits95: Bristol-Myers Squibb Co. - Product / Service
Exhibits96: Bristol-Myers Squibb Co. - Key offerings
Exhibits97: Eisai Co. Ltd. - Overview
Exhibits98: Eisai Co. Ltd. - Business segments
Exhibits99: Eisai Co. Ltd. - Key offerings
Exhibits100: Eisai Co. Ltd. - Segment focus
Exhibits101: Eli Lilly and Co. - Overview
Exhibits102: Eli Lilly and Co. - Business segments
Exhibits103: Eli Lilly and Co. - Key offerings
Exhibits104: Eli Lilly and Co. - Segment focus
Exhibits105: Eureka Therapeutics - Overview
Exhibits106: Eureka Therapeutics - Product / Service
Exhibits107: Eureka Therapeutics - Key offerings
Exhibits108: Gilead Sciences Inc. - Overview
Exhibits109: Gilead Sciences Inc. - Business segments
Exhibits110: Gilead Sciences Inc. - Key news
Exhibits111: Gilead Sciences Inc. - Key offerings
Exhibits112: Gilead Sciences Inc. - Segment focus
Exhibits113: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibits114: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibits115: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
Exhibits116: Lion TCR Pte. Ltd - Overview
Exhibits117: Lion TCR Pte. Ltd - Product / Service
Exhibits118: Lion TCR Pte. Ltd - Key offerings
Exhibits119: Merck and Co. Inc. - Overview
Exhibits120: Merck and Co. Inc. - Business segments
Exhibits121: Merck and Co. Inc. - Key news
Exhibits122: Merck and Co. Inc. - Key offerings
Exhibits123: Merck and Co. Inc. - Segment focus
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations